Holds two issued patents for early cardiac ischemia diagnostics. Leads translational cardiovascular research across preclinical models and human studies, spanning pharmacology, hypoxia biology, cardiac biomarkers, and exercise-based rehabilitation, with applications in oncology, COVID-19, and sports cardiology.